Focus On Drug's Cancer-Killing Potential, Judge Tells Biotech
A London judge ruled Friday that a pharmaceutical company had to focus on what its patented drug could do to kill cancer cells and advance research at the start of a...To view the full article, register now.
Already a subscriber? Click here to view full article